<DOC>
	<DOCNO>NCT00834977</DOCNO>
	<brief_summary>The objective study compare rate extent absorption amlodipine-benzazepril 10 mg-20 mg capsule ( test ) versus Lotrel® ( reference ) , administer 1 x 10 mg capsule fast condition .</brief_summary>
	<brief_title>Amlodipine-Benazepril 10mg-20mg Capsules Healthy Subjects Under Fasting Conditions</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Male nonchildbearing potential female , nonsmoker , 18 year age old . Nonchildbearing potential female subject define follow : Postmenopausal state : absence menses 12 month prior drug administration hysterectomy woth bilateral oophorectomy least 6 month prior drug administration . Surgically sterile : hysterectomy , bilateral oophorectomy , tubal ligation least 6 month prior drug administration . Capable consent Clinically significant illness within 4 week prior administration study medication . Clinically significant surgery within 4 week prior administration study medication Any clinically significant abnormality find medical screening . Any reason , opinion Medical SubInvestigator , would prevent subject participate study . Abnormal laboratory test judge clinically significant . Positive test hepatitis B , hepatitis C , HIV screen . EGC abnormality ( clinically significant ) vital sign abnormality ( systolic blood pressure low 100 ot 140 nnHg , diastolic blood pressure low 60 90 mmHg , heart rate less 60 100 bpm ) screening . BMI ≥ 30.0 History significant alcohol abuse within six month prior screen visit indication regular use fourteen unit alcohol per week ( 1 Unit= 150 mL wine , 360 mL beer , 45 mL ot 40 % alcohol ) positive alcohol breath test screening . History drug abuse use illegal drug : use soft drug ( marijuana ) within 3 month prior screen visit hard drug ( cocaine , phencyclidine [ PCP ] crack ) within 1 year prior screen visit positive urine drug screen screen . History allergic reaction heparin , amlodipine , benazepril , ACE inhibitor , relate drug . Use drug know induce hepatic drug metabolism ( examples inducer : barbiturate , carbamazepine , phenytoin , glucocorticoid , omeprazole ; examples inhibitor : antidepressant ( SSRI ) , cimetidine , diltiazem , macrolides , imidazole , neuroleptic , verapamil , fluoroquinolones , antihistamine ) within 30 day prior administration study medication . Use investigational drug participation investigational study within 30 day prior administration study medication . Clinically significant history presence clinically significant gastrointestinal pathology ( e.g . chronic diarrhea , inflammatory bowel disease ) , unresolved gastrointestinal symptom ( e.g . diarrhea , vomit ) , liver kidney disease , condition know interfere absorption , distribution , metabolism , excretion drug . Any clinically significant history presence clinically significant neurological , endocrinal , cardiovascular , pulmonary , hematologic , immunologic , psychiatric , metabolic disease . Use prescription medication ( include hormone replacement therapy ) within 14 day prior administration study medication overthecounter product ( include natural food supplement , vitamin , garlic supplement ) within 7 day prior administration study medication , except topical product without systemic absorption . Difficulty swallow study medication . Subjects use tobacco form within 90 day precede study drug administration Any food allergy , intolerance , restriction special diet , opinion Medical SubInvestigator , could contraindicate subject 's participation study . A depot injection implant drug within 3 month prior administration study medication . Donation plasma ( 500 mL ) within 30 day prior drug administration . Donation loss whole blood ( exclude volume blood drawn screening procedure study ) prior administration study medication follow : 50 mL 300 mL whole blood within 30 day , 301 mL 500 mL whole blood within 45 day , 500 mL whole blood within 56 day prior drug administration . Consumption food beverage contain grapefruit ( e.g . fresh , can , frozen ) within 7 day prior administration study medication . Intolerance venipunctures Unable understand unwilling sign Informed Consent Form . Clinically significant history angioedema . Subjects clinically significant history active hypotension . Subjects significant history active neutropenia and/or agranulocytosis . Breastfeeding subject . Positive urine pregnancy test screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>